Results 21 to 30 of about 1,040,958 (268)

Prolonged SARS-CoV-2 Infection and Organizing Pneumonia in a Patient with Follicular Lymphoma, Treated with Obinutuzumab—Challenging Recognition and Treatment

open access: yesViruses, 2023
A Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing coronavirus disease 2019 (COVID-19) led to a pandemic outbreak in 2019. COVID-19’s course and its treatment in immunocompromised patients are uncertain.
E. Łyżwa   +8 more
doaj   +1 more source

Nontuberculous Mycobacterial Lung Disease in the Patients with Cystic Fibrosis—A Challenging Diagnostic Problem

open access: yesDiagnostics, 2022
Background: Cystic fibrosis (CF) is an autosomal, recessive genetic disorder, caused by a mutation in the cystic fibrosis transmembrane conductance receptor regulator (CFTR) gene.
Dorota Wyrostkiewicz   +6 more
doaj   +1 more source

Factors Predictive for Immunomodulatory Therapy Response and Survival in Patients with Hypersensitivity Pneumonitis—Retrospective Cohort Analysis

open access: yesDiagnostics, 2022
Hypersensitivity pneumonitis (HP) is one of the interstitial lung diseases with clearly established diagnostic criteria. Nevertheless, pharmacologic treatment recommendations are still lacking. Most specialists use steroids as first-line drugs, sometimes
Katarzyna B. Lewandowska   +11 more
doaj   +1 more source

Pulmonary amyloidosis mimicking interstitial lung disease and malignancy - A case series with a review of a pulmonary patterns

open access: yesRespiratory Medicine Case Reports, 2021
Background: Amyloidosis is an uncommon condition, which results from accumulation of misfolded extracellular insoluble protein in tissues and organs of the body, causing its damage and dysfunction.
Katarzyna Zimna   +4 more
doaj   +1 more source

Tuberculous Pericarditis—Own Experiences and Recent Recommendations

open access: yesDiagnostics, 2022
Tuberculous pericarditis (TBP) accounts for 1% of all forms of tuberculosis and for 1–2% of extrapulmonary tuberculosis. In endemic regions, TBP accounts for 50–90% of effusive pericarditis; in non-endemic, it only accounts for 4%.
Małgorzata Dybowska   +6 more
doaj   +1 more source

Pulmonary Hypertension in the Course of Interstitial Lung Diseases—A Personalised Approach Is Needed to Identify a Dominant Cause and Provide an Effective Therapy

open access: yesDiagnostics, 2023
The prevalence of pulmonary hypertension (PH) complicating interstitial lung diseases (ILDs) is 3.5–15% at an early stage, and up to 90% in ILD patients listed for lung transplantation.
Aneta Kacprzak   +2 more
doaj   +1 more source

Phenotypes of Sarcoidosis-Associated Pulmonary Hypertension—A Challenging Mystery

open access: yesDiagnostics, 2023
Sarcoidosis has been a well-recognised risk factor for pulmonary hypertension (PH) for a long time, but still, the knowledge about this concatenation is incomplete.
Aneta Kacprzak   +2 more
doaj   +1 more source

Serum Levels of Interleukin-8 and Tumor Necrosis Factor-alpha in Coal Workers' Pneumoconiosis: One-year Follow-up Study

open access: yesSafety and Health at Work, 2010
Objectives: Various cytokines induced by inhalation of coal dust may mediate inflammation and lead to tissue damage or fibrosis, such as coal workers' pneumoconiosis (CWP).
Jong Seong Lee   +5 more
doaj   +1 more source

Imaging Plays a Key Role in the Diagnosis and Control of the Treatment of Bone Sarcoidosis

open access: yesBiomedicines, 2023
Sarcoidosis is a multisystem granulomatous disease of unknown origin. The most frequent localizations are thoracic lymph nodes and/or parenchymal lung disease, nevertheless any other organ may be involved.
Katarzyna Błasińska   +4 more
doaj   +1 more source

Severe Respiratory Failure Due to Pulmonary BCGosis in a Patient Treated for Superficial Bladder Cancer

open access: yesDiagnostics, 2022
Intra-vesical instillations with bacillus Calmette-Guerin (BCG) are the established adjuvant therapy for superficial bladder cancer. Although generally safe and well tolerated, they may cause a range of different, local, and systemic complications.
Katarzyna Lewandowska   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy